HOME >> BIOLOGY >> NEWS
ACS News Service Weekly PressPac -- April 11, 2007

Here is the latest American Chemical Society (ACS) News Service Weekly press package (PressPac) with reports selected from 35 major peer-reviewed journals and Chemical & Engineering News. With more than 160,000 members, ACS is the worlds largest scientific society.

ACS NEWS SERVICE April 11, 2007 Weekly PressPac ALL CONTENT IS FOR IMMEDIATE USE EXCEPT ARTICLE #5 (EMBARGOED FOR 9 A.M., EASTERN TIME, April 16, 2007)

PressPac Archive: http://www.chemistry.org/news/presspac.html

Contact: Michael Woods
202-872-4400
m_woods@acs.org

In This Edition:

  • Toward a noninvasive diagnostic test for women at high risk of preterm birth
  • A new test to screen fish for 25 drug residues at the same time
  • Cell phones qualify as hazardous waste, say researchers
  • Rapid, one-step, ultra-sensitive detection of food poisoning bacteria and biothreats
  • Bisphenol A on trial

Journalists Resources:

  • "Huh, a what?" Find out "what" in a Chemistry Glossary
  • Science Elements: ACS Audio Clips
  • News, features, background, sources from ACS National Meeting, March 25-29, Chicago
  • Research in one hot field: ACS Chemical Biology
  • Mark Your Calendars: ACS Regional Meeting, May 16-19, Philadelphia

This information is intended for your personal use in news gathering and reporting and should not be distributed to others. Anyone using advance ACS News Service Weekly Press Package information for stocks or securities dealing may be guilty of insider trading under the federal Securities Exchange Act of 1934. Please cite the individual journal, or the American Chemical Society, as the source of this information.

ARTICLE #1 FOR IMMEDIATE RELEASE

Toward a noninvasive diagnos
'"/>

Contact: Michael Woods
m_woods@acs.org
202-872-4400
American Chemical Society
16-Apr-2007


Page: 1 2 3 4 5 6 7 8 9

Related biology news :

1. ACS News Service Weekly PressPac -- May 23, 2007
2. ACS News Service Weekly PressPac -- May 16, 2007
3. ACS News Service Weekly PressPac -- May 9, 2007
4. ACS News Service Weekly PressPac -- May 2, 2007
5. ACS News Service Weekly PressPac -- April 25, 2007
6. ACS News Service Weekly PressPac -- April 18, 2007
7. ACS News Service Weekly PressPac -- March 28, 2007
8. ACS News Service Weekly PressPac -- March 21, 2007
9. ACS News Service Weekly PressPac -- March. 14, 2007
10. ACS News Service Weekly PressPac -- Feb. 21, 2007
11. ACS News Service Weekly PressPac -- February 14, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ACS News Service Weekly PressPac April

(Date:6/18/2013)... has awarded $12.7 million to match nine academic ... compounds to explore new treatments for patients in ... dystrophy and schizophrenia. The collaborative pilot initiative, called ... led by the National Center for Advancing Translational ... Fund. , The process of developing a new ...
(Date:6/18/2013)... of breast and ovarian cancers are familial in origin, ... to inherited mutations from the parents in genes such ... PARP inhibitors, which are currently in clinical trials, have ... for personalised cancer treatment, an alternative to standard chemotherapy. ... these patients generate resistance to the drug and, therefore, ...
(Date:6/17/2013)... in the U.S. exposed to high levels of air pollution ... a child with autism as women who lived in areas ... School of Public Health (HSPH). It is the first large ... across the U.S. , "Our findings raise concerns since, depending ... our study lived in areas where risk of autism was ...
Breaking Biology News(10 mins):NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2Exposure to high pollution levels during pregnancy may increase risk of having child with autism 2
(Date:6/18/2013)... -- RegeneCure announced today the start ... Bone Regeneration (GBR) Dental Membrane as a bone stimulating aid ... encountered when patients have a tooth replaced with a dental ... the implant. Consequently there is often a need to support ... regenerates. The bone substitute material, in turn, needs to be ...
(Date:6/18/2013)... , June 18, 2013 ... investment research firm, announces the initiation of ... French biopharmaceutical company developing and marketing products ... indications.      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) ... report examining the investment merits of BioAlliance ...
(Date:6/18/2013)... June 18, 2013 Mapi Pharma Ltd. ... and innovative intermediates, and finished dosage forms based on selected ... granted a United States patent for ... Europe for the oral treatment of moderate-to-severe acute ... Intermediate Compounds and Processes for the Preparation of Tapentadol ...
(Date:6/18/2013)... DUBLIN , June 18, 2013 /PRNewswire/ ... http://www.researchandmarkets.com/research/5g3rx5/dna_sequencing ) has announced the addition of ... Markets and Companies " to their offering. ... This report briefly reviews basics of human ... their applications. Current large and small sequencers ...
Breaking Biology Technology:RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 3Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2
Cached News: